An honest, use-case comparison of the top financial news terminals — institutional and retail. Where each one wins, what it costs, and which fits an independent trader best.
Basic plan always free (5-min delay, no credit card) · Pro zero-delay at €40/month
There is no single winner — it depends on budget and what you trade. The Bloomberg Terminal is the institutional leader (~$25,000/yr). For independent and retail traders, the best value is Trading News Terminal (real-time multi-asset news, squawk box, economic calendar; free Basic, €40/month Pro). Benzinga Pro is best for US-equity news, Newsquawk for an institutional squawk, Koyfin for data and research, FinancialJuice for a free squawk, and Investing.com for a broad free portal.
Best-fit use case, free tier and reported price for each. Figures are publicly reported and can change — confirm current terms with each vendor.
| Terminal | Best for | Free tier | Price (reported) |
|---|---|---|---|
| Bloomberg Terminal | Institutional desks, deepest data | ✗ | ~$25,000/yr |
| Benzinga Pro | US-equity news, earnings, ratings | ✗ | ~$37–$177+/mo |
| Newsquawk | Institutional audio squawk (desks) | ✗ | Enterprise / quoted |
| Koyfin | Data, dashboards, research | ✓ | Free–~$99/mo |
| FinancialJuice | Free live audio squawk | ✓ | Free |
| Investing.com | Broad free portal, reference | ✓ | Free (ads) |
| Trading News Terminal | Best value multi-asset news + squawk | ✓ | Free · €40/mo |
Ranked by overall value across institutional and retail tools. The “best” one is the one that fits your budget and the markets you trade.
The benchmark: the deepest cross-asset data, analytics, execution and the IB chat network, with top-tier news. Built for institutional desks at roughly $25,000 per user per year — overkill (and out of budget) for most individuals, but still the gold standard where money is no object.
The best value for independent and retail traders: real-time market-moving news across forex, indices, stocks, commodities, crypto and macro, with AI HIGH/MED/LOW impact classification, an audio squawk box, a live economic calendar, an 8-bank central bank tracker and TradingView charts. Free on Basic (5-minute delay) or €40/month on Pro (zero delay, squawk, live TV). Strongest where traders need speed and signal on news without institutional prices.
A fast, trader-focused news desk for US equities — breaking headlines, earnings, analyst ratings, scanners and an audio alert feed. Paid-only, with tiers reported from roughly $37 to $177+/month. Best if you trade US stocks and lean on ratings; lighter on forex, commodities and macro.
A top-tier, analyst-voiced institutional squawk and research service built for trading desks, usually sold business-to-business. Unmatched for a live human macro squawk on a desk; not self-serve for individuals.
The most-cited all-round data alternative to Bloomberg: dashboards, screeners, fundamentals, macro and watchlists, with a free tier. Excellent for research; lighter on real-time breaking-news speed and squawk — pairs well with a news-first terminal.
A popular free audio squawk and news feed. Great if your only need is a free voice reading headlines; lighter on structure (impact classification, tagging, a central bank tracker) than a full terminal.
A huge, free, general-purpose finance portal: news, quotes, a well-known economic calendar, charts and a portfolio. Broad and free, but ad-supported and consumer-oriented rather than a focused, fast trading terminal.
Start with budget. If cost is no object and you run an institutional desk, Bloomberg or LSEG Workspace. If you're an independent trader, you do not need to spend thousands — free and €40/month tools cover the news, calendar and charts you actually use.
Then match the markets you trade. US equities → Benzinga Pro. Forex and macro → Trading News Terminal, FXStreet or ForexLive. Research and data → Koyfin. A live institutional squawk → Newsquawk.
Decide if you need a squawk. If you want headlines read aloud hands-free, look at Newsquawk (desks), FinancialJuice (free) or Trading News Terminal (Pro).
Try the free tiers first. Trading News Terminal, Koyfin, FinancialJuice and Investing.com all let you start free — the fastest way to find the workflow that fits.
There is no single best — it depends on budget and what you trade. The Bloomberg Terminal is the institutional leader but costs around $25,000 per user per year. For independent and retail traders, the best value is Trading News Terminal (real-time multi-asset news, squawk box, economic calendar; free Basic, €40/month Pro). Benzinga Pro is best for US-equity news, Newsquawk for an institutional squawk, Koyfin for data and research, and FinancialJuice for a free squawk.
For a free start, Trading News Terminal's Basic plan gives a real-time news feed on a 5-minute delay with impact classification, an economic calendar and charts; Investing.com is a broad free portal; Koyfin has a free data tier; and FinancialJuice offers a free audio squawk. For a low flat price with zero-delay news and a squawk box, Trading News Terminal Pro is €40/month — far below institutional terminals.
For forex and macro, Trading News Terminal is a strong pick: multi-asset real-time news with per-currency tagging, an economic calendar and an 8-bank central bank tracker (Fed, ECB, BoE, BoJ, SNB, BoC, RBA, RBNZ), plus a squawk box. FXStreet and ForexLive are good forex-specific feeds, and Newsquawk is the institutional macro squawk for desks.
Newsquawk (institutional, analyst-voiced), FinancialJuice (free) and Trading News Terminal (in its €40/month Pro plan) all offer an audio squawk box that reads breaking headlines aloud. Bloomberg also has squawk capability within the terminal. Benzinga Pro includes an audio alert feed as well.
For most retail and independent traders, no — the Bloomberg Terminal is built for institutional desks at roughly $25,000 per user per year, and much of its depth (execution, institutional data, IB chat) goes unused by individuals. The news, calendar and charts that retail traders use most are available from tools like Trading News Terminal, Benzinga Pro and Koyfin at a tiny fraction of the cost.